Finance

Lists
Why is HEMO up 3.39%?
Dive Deeper
HEMO:LON
Hemogenyx Pharmaceuticals PLC
GBX 640.00
+3.39%
(+21.00) 1D
Oct 8, 4:35:10 PM GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for HEMO...
Open
GBX 674.00
High
GBX 680.00
Low
GBX 621.00
Mkt. cap
44.14M
Avg. vol.
29.02K
Volume
6.89K
52-wk high
GBX 1,329.35
52-wk low
GBX 356.00
EPS
-GBX 1.91
Shares outstanding
6.90M
No. of employees
16
Open
GBX 674.00
High
GBX 680.00
Low
GBX 621.00
Mkt. cap
44.14M
Avg. vol.
29.02K
Volume
6.89K
52-wk high
GBX 1,329.35
52-wk low
GBX 356.00
EPS
-GBX 1.91
Shares outstanding
6.90M
No. of employees
16
News stories
From web sources and news partners
About Hemogenyx Pharmaceuticals PLC
CEO-
Employees16
Founded2013
Headquarters-
SectorBiotechnology
Websitehemogenyx.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in GBP
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.06M
2.06M
848.18K
848.18K
Operating expense
2.16M
2.16M
3.69M
3.69M
Total operating expenses
2.16M
2.16M
3.69M
3.69M
Operating income
-2.16M
-2.16M
-3.69M
-3.69M
Other non operating income
-1.15M
-1.15M
-
-
EBT including unusual items
-2.38M
-2.38M
-3.28M
-3.28M
EBT excluding unusual items
-2.24M
-2.24M
-3.28M
-3.28M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-33.28K
-33.28K
-54.24K
-54.24K
Net income
-2.38M
-2.38M
-3.28M
-3.28M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
563.00
563.00
9.46K
9.46K
Interest expense
-54.83K
-54.83K
-47.62K
-47.62K
Net interest expenses
-54.27K
-54.27K
-38.17K
-38.17K
Depreciation and amortization charges
137.48K
137.48K
123.09K
123.09K
EBITDA
-2.13M
-2.13M
-3.66M
-3.66M
Gain or loss from assets sale
2.30K
2.30K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps